BPC-157 / TB-500

BPC-157 / TB-500 is a research peptide blend that combines two synthetic peptides examined in the regenerative and recovery literature. BPC-157 (Body Protection Compound-157) is a stable, synthetic pentadecapeptide whose sequence corresponds to a partial fragment of a protein identified in gastric juice, while TB-500 is a synthetic fragment corresponding to the active region of the naturally occurring protein Thymosin Beta-4. Combined as a single SKU within the recovery and tissue-research category, the blend is offered for laboratory research and professional reference use only. This material is not approved by the FDA for therapeutic use and is not intended to diagnose, treat, cure, or prevent any condition; it is supplied solely to support investigation by qualified researchers and licensed practitioners working within applicable regulations. Areas of scientific interest commonly associated with each component center on tissue-repair and cellular-migration pathways examined in preclinical models. Individual results vary, and no outcome is claimed or implied.

• Investigated in preclinical literature for processes related to soft-tissue and connective-tissue repair, including tendon, ligament, and muscle models
• Studied in research settings for its proposed influence on angiogenesis and the formation of new microvasculature during tissue remodeling
• Examined in laboratory models for cell migration and proliferation dynamics relevant to wound-healing pathways
• Reported in research contexts for interactions with growth-factor and actin-regulating signaling associated with recovery processes
• Explored in preclinical studies for gastrointestinal and musculoskeletal models of tissue protection and regeneration; reported research observations are model-dependent and individual results vary

For research and professional reference only. Lyophilized peptide is typically stored frozen and protected from light and moisture until use; many facilities keep unreconstituted vials in a freezer (commonly at or below minus 20 degrees Celsius) for long-term stability. Reconstitution is generally performed with bacteriostatic water or another suitable sterile diluent selected by the researcher, adding the diluent slowly against the vial wall and allowing the powder to dissolve without vigorous shaking. After reconstitution, the solution is usually kept refrigerated (commonly 2 to 8 degrees Celsius), protected from light, and handled using sterile technique to limit contamination and degradation. Avoid repeated freeze-thaw cycles, inspect for particulates or discoloration before use, and follow your facility's standard operating procedures and all applicable safety and disposal regulations. No specific dosing, frequency, or administration protocol is provided here. Any research or clinical protocol, including handling parameters and any decision regarding use, is determined solely by the licensed ordering provider; this is reference information only and not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published preclinical literature, BPC-157 is studied for its proposed interaction with angiogenic and growth-factor signaling, including effects reported on nitric oxide pathways and on the upregulation of receptors implicated in new blood-vessel formation, which researchers have associated with tissue-repair responses observed in animal models. TB-500, as a fragment corresponding to the active site of Thymosin Beta-4, is investigated primarily for its proposed role in binding and regulating actin, a cytoskeletal protein, thereby influencing cell migration, proliferation, and differentiation during tissue remodeling. The rationale for combining the two in research is that their proposed mechanisms are studied as potentially complementary within recovery-related pathways. These mechanisms remain under investigation and are described here for reference only; individual results vary and no therapeutic effect is established or claimed.